Cesca Therapeutics Inc. , an autologous cell-based regenerative medicine company, today reported financial results for the first quarter of fiscal 2015 and reported on the progress of its clinical programs. "We have made important progress advancing our clinical programs during the first quarter of fiscal 2015," said Robin C. Stracey, Chief Executive Officer of Cesca Therapeutics.
http://ift.tt/1ELi3xs
http://ift.tt/1ELi3xs
No comments:
Post a Comment